心脏特异性肌钙蛋白- 1 (cTnI)在死后的设置。

IF 2.3 3区 医学 Q1 MEDICINE, LEGAL
Ethan D Sutton, Sarah Parsons, Maria Pricone, Hans H de Boer
{"title":"心脏特异性肌钙蛋白- 1 (cTnI)在死后的设置。","authors":"Ethan D Sutton, Sarah Parsons, Maria Pricone, Hans H de Boer","doi":"10.1007/s00414-025-03526-x","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death.Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times.Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret.We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.</p>","PeriodicalId":14071,"journal":{"name":"International Journal of Legal Medicine","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiac-specific troponin-I (cTnI) in a post-mortem setting.\",\"authors\":\"Ethan D Sutton, Sarah Parsons, Maria Pricone, Hans H de Boer\",\"doi\":\"10.1007/s00414-025-03526-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death.Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times.Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret.We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.</p>\",\"PeriodicalId\":14071,\"journal\":{\"name\":\"International Journal of Legal Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Legal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00414-025-03526-x\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, LEGAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Legal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00414-025-03526-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, LEGAL","Score":null,"Total":0}
引用次数: 0

摘要

心肌特异性肌钙蛋白(cTn)在临床医学中广泛用于支持急性心肌梗死的诊断。有几项研究探讨了cTn检测在已故个体中的价值。这些研究表明,尽管存在与使用相关的重要限制,但死后cTn在某些情况下是有用的。然而,对死后cTn检测的决定应受到尚未详细探讨的因素的影响。这包括死后cTn检测的成功率,以及cTn水平在死后是否稳定。因此,本研究探讨了心肌特异性肌钙蛋白I (cTnI)的死后可用性和稳定性。通过分析250种对死后血液样本进行高灵敏度(hs-)cTnI测试的成功率,以及其与样本位置、样本类型、死后间隔和分解等变量的关系,确定了死后可用性。通过比较同一个体在不同时间采集的两个样本的死后cTnI水平,探讨了死后稳定性。死后hs-cTnI测试成功率为86.4%(216/250),性别、年龄或心肺复苏的影响很小。可见的分解妨碍了成功的测试。其他与分解相关的变量(例如增加的死后时间间隔)也会对测试成功产生负面影响。我们的结果进一步表明,cTnI在死后非常不稳定,来自同一个体的样品之间的hs-cTnI测试结果存在显着差异。差异很大(平均18734 ng/L),而且不是单向的。不稳定性似乎随着时间间隔的增加而增加,但结果总体上是不稳定的,难以解释。我们的结论是,hs-cTnI检测结果通常可以在死后获得,但应该在最早可用的血液样本上进行检测。腐烂个体的样本不应进行测试。此外,cTnI的严重不稳定性表明,任何尸检hs-cTnI结果必须谨慎解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cardiac-specific troponin-I (cTnI) in a post-mortem setting.

Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death.Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times.Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret.We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.80
自引率
9.50%
发文量
165
审稿时长
1 months
期刊介绍: The International Journal of Legal Medicine aims to improve the scientific resources used in the elucidation of crime and related forensic applications at a high level of evidential proof. The journal offers review articles tracing development in specific areas, with up-to-date analysis; original articles discussing significant recent research results; case reports describing interesting and exceptional examples; population data; letters to the editors; and technical notes, which appear in a section originally created for rapid publication of data in the dynamic field of DNA analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信